AKT1 and neoplasm: ERBIN interacted with the oncogenic ERBB2 tyrosine kinase receptor and was reported as a promoter of tumor growth by ERBB2 [28] and as a tumor suppressor by negatively regulating both Akt and RAF/MEK/ERK signaling [29].